How Companies in Indonesia Can Source Pharma Products & CDMO Services (2026 Guide)

Indonesia is the largest pharmaceutical market in Southeast Asia by population, and demand keeps rising for chronic-disease medicines, antibiotics, injectables and hospital supplies. The country has a large local formulation industry, but it still imports most of the active pharmaceutical ingredients (APIs) it uses, along with many specialty and sterile finished products.

For buyers, the challenge is less about finding a supplier and more about finding one that can pass BPOM review, meet halal rules where they apply, and fit the government's push for local manufacturing. This guide explains where supply typically comes from, how to qualify a manufacturer or CDMO, which documents you need, and the regulatory points that most often slow Indonesian projects down.

Indonesian buyers usually draw on several supply bases, each with different strengths:

Many companies dual-source: one cost-focused supplier for high-volume generics and a second, often EU-GMP or PIC/S-inspected, site for sterile or critical products. Because API supply is concentrated in a small number of countries, a qualified backup source is worth the extra paperwork.

APIs for local manufacturing

This is the biggest import category. Local manufacturers buy antibiotics (amoxicillin, cephalosporins), analgesics such as paracetamol, antidiabetics such as metformin, proton-pump inhibitors and cardiovascular APIs such as atorvastatin.

Finished dosage forms

• Tablets, capsules, syrups, dry powders and sachets for chronic and acute care
• Paediatric formulations and OTC products
• Oncology, immunology and other specialty products not yet made locally

Injectables and sterile products

Cephalosporin injectables, lyophilised vials, small-volume parenterals and oncology injectables, mostly for hospitals and JKN-funded care.

Nutraceuticals and CDMO work

Vitamins, herbal and traditional products, and private-label OTC lines. Buyers also contract formulation development, technology transfer and contract packaging, often as part of a plan to make the product locally later.

1. Define the requirement. List molecule, strength, dosage form, pack size, annual volume, whether you need an API or a finished product, and whether the product is already registered in Indonesia.
2. Check halal and local-content needs early. If the product falls into a halal-mandatory category or is aimed at the e-Katalog, these points will shape your supplier choice.
3. Shortlist and verify suppliers. Confirm GMP certificates (WHO-GMP, EU-GMP or PIC/S-member inspections) against the issuing authority's records and ask for recent inspection outcomes. Our supplier verification guide covers the checks in detail.
4. Review the technical file. Ask for the CoA, COPP, a dossier in ACTD format, stability data at Zone IVB conditions (30°C/75% RH) and, for APIs, a DMF or CEP with impurity profile.
5. Run a pilot. Test samples in a local or accredited lab before committing to large volumes.
6. Agree commercial terms. MOQ, Bahasa Indonesia artwork, lead times, Incoterms and payment terms (LC or TT).

PharmaTradz works with GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa. You can post your requirement through the RFQ page and compare verified offers side by side.

Main entry points

• Sea: Tanjung Priok (Jakarta), Tanjung Perak (Surabaya) and Belawan (Medan)
• Air: Soekarno-Hatta International Airport (Jakarta), Juanda (Surabaya) and Kualanamu (Medan)

Indicative transit

Air freight from Asian or European hubs typically takes 2–5 days door to airport. Sea freight from South or East Asia typically takes 1–3 weeks, while sailings from Europe typically take 4–6 weeks, plus clearance time.

Cold chain and terms

Vaccines, biologics and many injectables need 2–8°C handling with data loggers and GDP-qualified forwarders. Most API buyers use FOB or CIF, while finished-product buyers often prefer CIP or DAP so that the supplier manages the cold chain up to arrival. See our cold chain logistics service for temperature-sensitive cargo.

Customs

Customs clearance runs through INSW. The SKI must be in place before the goods arrive, so apply as soon as the shipment is confirmed. Make sure the HS code, batch numbers and quantities match across every document.

BPOM registration

The Badan Pengawas Obat dan Makanan (BPOM) regulates medicines. A marketing authorisation (NIE) must be held by an Indonesian legal entity with the right pharmaceutical licence. A foreign manufacturer cannot hold it directly. Dossiers are submitted in ACTD format through BPOM's e-Reg system. Authorisations are typically valid for five years and must be renewed before they lapse.

Foreign GMP evaluation

For imported medicines, BPOM evaluates the foreign site's GMP compliance against CPOB, Indonesia's GMP standard. This can include a desk review, a site inspection and a CAPA review, which adds time to the registration.

Labelling and stability

Labels, inner and outer packs and the package insert must be in Bahasa Indonesia. Stability data should cover Zone IVB conditions.

Halal requirements (BPJPH)

Under the Halal Product Assurance law, the Halal Product Assurance Agency (BPJPH) is phasing in mandatory halal certification. Traditional medicines and health supplements come first, followed by OTC medicines and later prescription drugs. Products with non-halal materials must carry a clear non-halal statement. Ask suppliers about animal-derived excipients, gelatin capsules and processing aids early.

Local manufacturing and TKDN

Government policy favours local production. Listing in the national e-Katalog, used for most public purchasing, depends on a minimum local-content (TKDN) score, and medicines made with locally produced raw materials get priority. Importers who want long-term public-sector business should expect to discuss technology transfer or local contract manufacturing with their partners.

Special access

BPOM allows limited import of unregistered medicines through a special access route, for example for government programmes, donations or named-patient needs. It is not a substitute for registration.

Sourcing for Indonesia works best when supply choice, BPOM registration, halal status and local-content strategy are planned together. Use cost-competitive Asian supply for high-volume generics and APIs, EU-GMP or US sources for complex and sterile products, and keep a second qualified supplier for critical lines.

PharmaTradz connects Indonesian buyers with GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa. For more on the local market, visit our Indonesia country hub, or get help with dossier preparation and registration.

Frequently Asked Questions

Can a foreign manufacturer register a medicine with BPOM directly?

No. The marketing authorisation must be held by a licensed Indonesian legal entity, usually a local pharmaceutical company or appointed partner.

Which dossier format does BPOM accept?

BPOM uses the ASEAN Common Technical Dossier (ACTD), submitted through its e-Reg system.

Do imported medicines need halal certification in Indonesia?

It depends on the category. BPJPH is phasing in halal rules, starting with traditional medicines and supplements, then OTC and later prescription drugs. Non-halal products must be labelled as such.

What is TKDN and why does it matter?

TKDN is the local-content score. It affects whether a medicine can be listed in the e-Katalog, which drives most public-sector purchasing.

Is an import certificate needed for each shipment?

Yes. BPOM issues an SKI for imports of medicines and pharmaceutical raw materials, processed through INSW before customs clearance.

Which stability zone applies to Indonesia?

Zone IVB (30°C/75% RH). Data from other zones usually needs supporting or bridging studies.